Innovative Approaches

Intellectual Property Portfolio

Geron protects its investments in new technologies through a carefully managed program of international intellectual property protection. Our patent portfolio covers innovations arising from our internal research as well as technologies created in conjunction with collaborators and in-licensed patents. Imetelstat, a product of our internal research programs, is covered by multiple patent families including those relating to our proprietary nucleic acid chemistry and telomerase technologies. GRN1005, in-licensed on an exclusive, worldwide basis from Angiochem, is covered by patent families including those relating to the LRP-directed peptide technology.